Charanjit Singh Joins Solo-Dex, Inc. Board of Directors

WOLF CREEK, MT / ACCESSWIRE / August 31, 2023 / Solo-Dex, a leading innovator in the healthcare technology industry, is pleased to announce the appointment of Charanjit Singh as a new member of its Board of Directors, effective August 23, 2023. This strategic addition to the leadership team reflects Solo-Dex’s commitment to professionalism, innovation and expertise as the company continues to grow and expand its operations.

Charanjit Singh brings a wealth of experience and a diverse skill set to his role on the Board of Directors. With a distinguished career spanning over two decades, he has served on the boards of 10 private and public entities, and made significant contributions to the fields of technology, business strategy, and corporate governance. His expertise in aligning business goals with marketing and technological advancements will be invaluable to Solo-Dex as it navigates the evolving landscape of the medical technology market.

“We are thrilled to welcome Charanjit Singh to the Solo-Dex family as a member of our Board of Directors,” said Steven Eror, CEO of Solo-Dex, Inc. “His extensive background in strategic planning, conceptualizing profitable growth strategies, implementing financial controls, overseeing mergers and acquisitions, and fostering corporate social responsibility and governance will provide us with fresh perspectives and insights that will undoubtedly contribute to our strategic direction and long-term growth.”

“I am honored to join Solo-Dex, Inc. as a member of the Board of Directors,” said Charanjit Singh. “I look forward to collaborating with the talented team at Solo-Dex to help accelerate the company’s business and drive its continued success in the MedTech industry.”

As Solo-Dex, Inc. continues to expand its portfolio and explore new avenues for growth, the addition of Charanjit Singh to the Board of Directors marks an exciting chapter in the company’s journey. His wealth of knowledge and unique insights will contribute to shaping the strategic direction of Solo-Dex, reinforcing its position as a leader in the Healthcare Technology Sector.

About Solo-Dex, Inc.:

Solo-Dex, Inc. is a private MedTech company dedicated to the efficient and effective management of acute pain and the reduction of prescription opioid abuse. With a strong commitment to innovation and excellence, Solo-Dex has been nominated for Best MedTech Device by the Prix Galien Foundation and is actively addressing markets in North America, the Middle East and India. The Company is headquartered in Wolf Creek, Montana and is renowned for its breakthrough easy-to-use devices for the placement of continuous peripheral nerve blocks for pain before, during and after surgery for up to five days.

For media inquiries, please contact:

Solo-Dex, Inc.
1576 MT Highway 434
Wolf Creek, MT 59648
Office: (801) 631-7288
Email: info@solo-dex.com

Website: www.solo-dex.com

SOURCE: Solo-Dex, Inc.